文献速递临床试验与 GCP

桃金娘果实治疗疑似COVID-19患者的随机对照试验方案

Evaluating the efficacy and safety of the myrtle (Myrtus communis) in treatment and prognosis of patients suspected to novel coronavirus disease (COVID-19): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2020-11-26

本研究为开放标签随机对照试验,纳入18-65岁临床疑似COVID-19的轻中度门诊患者,比较桃金娘果实制剂联合常规治疗与单纯常规治疗的疗效与安全性。干预持续5天,随访至14天,评估临床状态、死亡率及不良反应。

要点

  • 桃金娘组在常规治疗基础上加用桃金娘果实制剂,干预5天。
  • 研究对象为18-65岁轻中度疑似COVID-19门诊患者,无呼吸窘迫。
  • 主要结局包括临床状态、死亡率和不良反应,随访至14天。

核心结论

  • 该方案旨在为桃金娘果实水提取物治疗临床疑似COVID-19提供证据并识别安全性问题。

研究设计与样本

  • 开放标签随机对照试验,纳入18-65岁临床疑似COVID-19的轻中度门诊患者,无呼吸窘迫。

关键数值与推荐

  • 干预持续5天,结局包括临床状态、死亡率和不良反应,测量至14天。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Since December 2019, the outbreak of coronavirus pneumonia was observed in China and quickly propagate in all of the world. Nowadays, many trials are underway on this disease in which the efficacy of various therapeutic remedies including chemical or natural agents as well as different non-pharmacological methods such as acupuncture are evaluated. This study aims at investigating the effect of M. communis fruit for treatment of COVID-19 disease. METHODS: We are performing an open-label randomized controlled trial on outpatients clinically suspected to COVID-19 disease in the age range of 18-65 years old with mild to moderate symptoms and without respiratory distress. Patients in both groups (M. communis and control) receive conventional therapy, but those in M. communis group get M. communis preparation in addition to conventional therapy. Intervention will continue for 5 days and the study outcomes including clinical status as well as mortality rate and adverse effects will be measured up to 14 days. DISCUSSION: The protocol describes the design of an ongoing randomized controlled trial to establish the evidence for the usage of water extract of M. communis fruit in clinically suspected COVID-19 disease and identify any safety concerns. TRIAL REGISTRATION: The trial has been registered at the Iranian Registry of Clinical Trials website under the code IRCT20180923041093N3 on March 28th, 2020 ( https://www.irct.ir/trial/46721 ). The results will be disseminated through manuscript publications and presentations to scientific meetings.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Azimi M, Hasheminasab FS. Evaluating the efficacy and safety of the myrtle (Myrtus communis) in treatment and prognosis of patients suspected to novel coronavirus disease (COVID-19): study protocol for a randomized controlled trial. Trials. 2020. PMID: 33243284. doi:10.1186/s13063-020-04915-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。